Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Stewardship Health sale to private equity finalized for $245M
The physician group, once part of Steward Health Care, has been rebranded as Revere Medical.
Baxter producing IV solutions ahead of schedule at Asheville-area site
The company said its largest production line at its North Carolina plant is operational, accounting for 25% of total output. The site was damaged by flood waters from Hurricane Helene.
Hackers were inside an Iowa hospital’s network for two weeks
St. Anthony Regional Hospital confirmed patient data was taken by cybercriminals, but the August incident is still being investigated.
Bill introduced in Congress would raise physician reimbursement by 1.9%
The Medicare Patient Access and Practice Stabilization Act aims to change the annual Centers for Medicare and Medicaid Services physician fee schedule, which cut reimbursement by 2.8% for 2025.
Good AI governance can spell the difference between smashing success and mere learning experience
Discussions of AI governance may cause many an eye to glass over, but the discipline is as crucial to the ascent of AI in healthcare as big training datasets drawn from diverse patient populations.

Recondo Technology Closes $16 million Funding Round to Support Exponential Growth to Power the Healthcare Revenue Cycle

Greenwood Village, CO—November 3, 2016—Recondo Technology, the market leader in cloud-based single-platform revenue cycle management solutions, announced today that it closed an additional $16 million in debt and capital funding to support and accelerate the company’s future growth curve. Lehmi Ventures led the round, with Bridge Capital serving as the debt partner.

November 8, 2016

Opinion: Marijuana could curb reliance on opioids for pain relief

Esther K. Choo, MD, MPH, and colleagues urge for a universal standing on cannabis as the solution to the opioid epidemic.

November 7, 2016

New dry-powder asthma inhaler receives FDA clearance

Propeller Health, a producer of digital products for respiratory medication, has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the GSK's Ellipta inhaler and platform, a treatment for asthma featuring a patented dry-powder inhaler.

November 7, 2016

Opioid poisonings skyrocket in American youths

America is in the grips of an epidemic, this epidemic isn’t driven by a mysterious virus but rather a drug being prescribed every day. Opioid use has increased at an unprecedented rate, leading to addictions and overdoses among the masses, and those effected aren’t limited to adults.

November 4, 2016

Sutter Health seeks to prevent self-insured companies from suing over prices

Sacramento, California-based Sutter Health is being accused of strong-arming companies into waiving their rights to sue the 24-hospital system, according to KQED.

November 4, 2016

Q&A: Deloitte's Andreaa Balan-Cohen on moving physicians towards value-based care

Some 94 percent of executives at provider organizations say they’re on the path towards value-based care, according to the Deloitte Center for Health Solutions, but only 27 percent say they’ve completed some stage of that transition. What may be holding the transformation back is how physicians are compensated.

November 4, 2016

Mylan settlement ‘irresponsible,’ says West Virginia Attorney General

The $465 million settlement over claims Mylan profited off an improper CMS classification of its EpiPen autoinjector isn’t good enough, according to West Virginia Attorney General Patrick Morrissey.

November 3, 2016

Part D prescriber enrollment requirement delayed to 2019

CMS has announced it will push back a requirement for prescribers be enrolled in Medicare for Part D to cover their prescriptions, marking at least the fourth time the agency has delayed the rule since it was finalized in March 2014.

November 3, 2016

Around the web

Cardiovascular Business

Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.

Cardiovascular Business

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.

Policy & Regulations

Stewardship Health sale to private equity finalized for $245M

Baxter producing IV solutions ahead of schedule at Asheville-area site

Hackers were inside an Iowa hospital’s network for two weeks

Bill introduced in Congress would raise physician reimbursement by 1.9%

Good AI governance can spell the difference between smashing success and mere learning experience

Around the web